|
Volumn 35, Issue 7, 2004, Pages 781-784
|
Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, PA
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRACYCLINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EPIRUBICIN;
ESTROGEN RECEPTOR;
KI 67 ANTIGEN;
PROGESTERONE RECEPTOR;
PROTEIN P53;
ADVANCED CANCER;
ASPIRATION BIOPSY;
BREAST CANCER;
BREAST CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER HORMONE THERAPY;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURGERY;
CONFERENCE PAPER;
DRUG INDICATION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
PATHOLOGY;
SENTINEL LYMPH NODE BIOPSY;
TREATMENT INDICATION;
TUMOR BIOPSY;
BREAST NEOPLASMS;
CARCINOMA;
FEMALE;
HUMANS;
NEOADJUVANT THERAPY;
PHILADELPHIA;
|
EID: 3142534410
PISSN: 00468177
EISSN: None
Source Type: Journal
DOI: 10.1016/j.humpath.2004.02.006 Document Type: Conference Paper |
Times cited : (30)
|
References (0)
|